US flag Official website of the Department of Homeland Security

Home >> News

Notice of Issuance of Final Determination Concerning Certain Pharmaceutical Products

This document provides notice that U.S. Customs and Border Protection (``CBP'') has issued 11 final determinations concerning the country of origin of certain pharmaceutical products. Based upon the facts presented, CBP has concluded that the country of origin of the Rosuvastatin Calcium Tablets, Levofloxacin Tablets, Levetiracetam Tablets, Metoprolol Tartrate Tablets, Gabapentin Capsules, Carvedilol Tablets, Paroxetine Hydrochloride Tablets, Entecavir Tablets, Montelukast Sodium Tablets, Simvastatin Tablets, Donepezil Hydrochloride Tablets is India for purposes of U.S. Government procurement.

Monday, February 5, 2018
83 FR 5118 (February 5, 2018)
Last modified: 
February 5, 2018